These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33440895)

  • 1. A COVID-19 Vaccine: Big Strides Come with Big Challenges.
    Mellet J; Pepper MS
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33440895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
    Sharma O; Sultan AA; Ding H; Triggle CR
    Front Immunol; 2020; 11():585354. PubMed ID: 33163000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on Promising vaccine development progress for COVID-19 disease.
    Belete TM
    Vacunas; 2020; 21(2):121-128. PubMed ID: 32837460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of current COVID-19 vaccine platforms.
    Nagy A; Alhatlani B
    Comput Struct Biotechnol J; 2021; 19():2508-2517. PubMed ID: 33936564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Platforms: Challenges and Safety Contemplations.
    Al-Jighefee HT; Najjar H; Ahmed MN; Qush A; Awwad S; Kamareddine L
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 Vaccines: Recent Development, Challenges and Prospects.
    Yan Y; Pang Y; Lyu Z; Wang R; Wu X; You C; Zhao H; Manickam S; Lester E; Wu T; Pang CH
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33916489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
    Flanagan KL; Best E; Crawford NW; Giles M; Koirala A; Macartney K; Russell F; Teh BW; Wen SC
    Front Immunol; 2020; 11():579250. PubMed ID: 33123165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
    Khuroo MS; Khuroo M; Khuroo MS; Sofi AA; Khuroo NS
    J Clin Exp Hepatol; 2020; 10(6):610-621. PubMed ID: 32837093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 basics and vaccine development with a Canadian perspective.
    Liu M; Chen X
    Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest updates on COVID-19 vaccines.
    Li Q; Lu H
    Biosci Trends; 2021 Jan; 14(6):463-466. PubMed ID: 33390384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2.
    Rego GNA; Nucci MP; Alves AH; Oliveira FA; Marti LC; Nucci LP; Mamani JB; Gamarra LF
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32854391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platforms Exploited for SARS-CoV-2 Vaccine Development.
    Mathew S; Faheem M; Hassain NA; Benslimane FM; Thani AAA; Zaraket H; Yassine HM
    Vaccines (Basel); 2020 Dec; 9(1):. PubMed ID: 33375677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar T; Raut D; Bhatt LK
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.